Poznanski SM[au] - Search Results

Year	Number of Results
2017	4
2018	5
2019	2
2020	1
2021	5
2022	2
2024	1

1

What Defines NK Cell Functional Fate: Phenotype or Metabolism?

Poznanski SM, Ashkar AA. Poznanski SM, et al. Front Immunol. 2019 Jun 19;10:1414. doi: 10.3389/fimmu.2019.01414. eCollection 2019. Front Immunol. 2019. PMID: 31275330 Free PMC article. Review.

2

Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment.

Poznanski SM, Singh K, Ritchie TM, Aguiar JA, Fan IY, Portillo AL, Rojas EA, Vahedi F, El-Sayes A, Xing S, Butcher M, Lu Y, Doxey AC, Schertzer JD, Hirte HW, Ashkar AA. Poznanski SM, et al. Cell Metab. 2021 Jun 1;33(6):1205-1220.e5. doi: 10.1016/j.cmet.2021.03.023. Epub 2021 Apr 13. Cell Metab. 2021. PMID: 33852875 Free article.

3

Aging and Interferons: Impacts on Inflammation and Viral Disease Outcomes.

Feng E, Balint E, Poznanski SM, Ashkar AA, Loeb M. Feng E, et al. Among authors: poznanski sm. Cells. 2021 Mar 23;10(3):708. doi: 10.3390/cells10030708. Cells. 2021. PMID: 33806810 Free PMC article. Review.

4

Asthma exacerbations on benralizumab are largely non-eosinophilic.

Poznanski SM, Mukherjee M, Zhao N, Huang C, Radford K, Ashkar AA, Nair P. Poznanski SM, et al. Allergy. 2021 Jan;76(1):375-379. doi: 10.1111/all.14514. Epub 2020 Aug 7. Allergy. 2021. PMID: 32767484 No abstract available.

5

Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function.

Poznanski SM, Barra NG, Ashkar AA, Schertzer JD. Poznanski SM, et al. Inflamm Res. 2018 Oct;67(10):813-828. doi: 10.1007/s00011-018-1174-3. Epub 2018 Jul 31. Inflamm Res. 2018. PMID: 30066126 Review.

6

Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity.

Poznanski SM, Portillo A, Mukherjee M, Bhalla A, Son K, Ashkar AA, Khalidi N, Nair P. Poznanski SM, et al. Eur Respir J. 2022 Apr 7;59(4):2102210. doi: 10.1183/13993003.02210-2021. Print 2022 Apr. Eur Respir J. 2022. PMID: 34887323 Free article. No abstract available.

7

Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment.

Moinuddin A, Poznanski SM, Portillo AL, Monteiro JK, Ashkar AA. Moinuddin A, et al. Among authors: poznanski sm. Immunol Rev. 2024 Mar 9. doi: 10.1111/imr.13316. Online ahead of print. Immunol Rev. 2024. PMID: 38459782 Review.

8

Type I interferon regulates proteolysis by macrophages to prevent immunopathology following viral infection.

Lee AJ, Feng E, Chew MV, Balint E, Poznanski SM, Giles E, Zhang A, Marzok A, Revill SD, Vahedi F, Dubey A, Ayaub E, Jimenez-Saiz R, McGrath JJC, Ritchie TM, Jordana M, Jonigk DD, Ackermann M, Ask K, Miller M, Richards CD, Ashkar AA. Lee AJ, et al. Among authors: poznanski sm. PLoS Pathog. 2022 May 5;18(5):e1010471. doi: 10.1371/journal.ppat.1010471. eCollection 2022 May. PLoS Pathog. 2022. PMID: 35512020 Free PMC article.

9

Shining light on the significance of NK cell CD56 brightness.

Poznanski SM, Ashkar AA. Poznanski SM, et al. Cell Mol Immunol. 2018 Dec;15(12):1071-1073. doi: 10.1038/s41423-018-0163-3. Epub 2018 Oct 1. Cell Mol Immunol. 2018. PMID: 30275534 Free PMC article. No abstract available.

10

Type I Interferon Receptor on NK Cells Negatively Regulates Interferon-γ Production.

Lee AJ, Mian F, Poznanski SM, Stackaruk M, Chan T, Chew MV, Ashkar AA. Lee AJ, et al. Among authors: poznanski sm. Front Immunol. 2019 Jun 4;10:1261. doi: 10.3389/fimmu.2019.01261. eCollection 2019. Front Immunol. 2019. PMID: 31214198 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

19 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year